Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

RICHMOND, Va., January 14, 2026 – Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced a major advancement in AI-driven Active ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by 2033, growing at a 6.46% CAGR. This ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

LAKE FOREST, Ill., Aug. 29, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced an agreement for Hospira to ...

Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...

Here's an insight into the changing Indian pharmaceutical landscape from being the largest generic drug supplier to a hub for innovation-led API manufacturing. The Indian pharmaceutical industry has ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...